Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (301130.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap2.18B
Enterprise Value2.17B
P/E Ratio-370.06
PEG Ratio3.28
Price/Sales Ratio9.54
Price/Book Ratio2.11
Enterprise/Revenue9.34
Enterprise/EBITDA246.78

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin-0.02
Operating Margin-0.07
AD

Management Effectiveness

Return On Assets-0
Return On Equity-0.01

Income Statement

Revenue234.84M
Revenue/Share2.59
Gross Profit179.1M
EBITDA56.88M
Net Income21.9M
Diluted EPS0.29

Balance Sheet

Total Cash229.54M
Total Cash/Share3.04
Total Debt40.56M
Total Debt/Equity0.05
Current Ratio3.47
Book Value Per Share11.9

Price History

52-Week Change-22.3
52-Week High39.98
52-Week Low21.88
Moving Average 50 Days26.95
Moving Average 200 Days28.65

Statistics

Average Volume7.18M
Shares Outstanding76.49M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.14
Trailing Annual Dividend Yield0.6
Payout Ratio-2.41
Last Split FactorN/A
Last Split DateN/A
AD